Last checked at 16 Dec 2021 07:00
16 December 2021
ACCROL GROUP HOLDINGS PLC("Accrol", the "Company" or the "Group")
AIM: ACRL
NOTICE OF HALF YEAR RESULTS
AND
ONLINE INVESTOR PRESENTATION
Accrol, the UK's leading independent tissue converter, announces that it will release its Half Year Results for the six months to 31 October 2021 on Tuesday, 18 January 2022.
An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.
As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Thursday, 20 January 2022 at 12.45pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H122.
For further information, please contact: | |
Accrol Group Holdings plc | |
Dan Wright, Executive Chairman | Via Belvedere Communications |
Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer | |
Zeus Capital Limited (Nominated Adviser & Broker) | |
Dan Bate / Jordan Warburton | Tel: +44 (0) 161 831 1512 |
Dominic King | Tel: +44 (0) 203 829 5000 |
Liberum Capital Limited (Joint Broker) | Tel: +44 (0) 20 3100 2222 |
Clayton Bush / Edward Thomas | |
Belvedere Communications Limited | |
Cat Valentine | Tel: +44 (0) 7715 769 078 |
Keeley Clarke | Tel: +44 (0) 7967 816 525 |
| |
accrolpr@belvederepr.com |
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.
For more information, please visit www.accrol.co.uk.